agplus diagnostics ltd
agplus diagnostics ltd Company Information
Company Number
06994240
Website
www.agplusdiagnostics.comRegistered Address
66 lincoln's inn fields, london, WC2A 3LH
Industry
Other research and experimental development on natural sciences and engineering
Manufacture of medical and dental instruments and supplies
Telephone
01234867100
Next Accounts Due
September 2024
Group Structure
View All
Shareholders
agplus holdings limited 100%
agplus diagnostics ltd Estimated Valuation
Pomanda estimates the enterprise value of AGPLUS DIAGNOSTICS LTD at £359.4k based on a Turnover of £415.5k and 0.87x industry multiple (adjusted for size and gross margin).
agplus diagnostics ltd Estimated Valuation
Pomanda estimates the enterprise value of AGPLUS DIAGNOSTICS LTD at £0 based on an EBITDA of £-828.8k and a 4.88x industry multiple (adjusted for size and gross margin).
agplus diagnostics ltd Estimated Valuation
Pomanda estimates the enterprise value of AGPLUS DIAGNOSTICS LTD at £0 based on Net Assets of £-4.9m and 2.27x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Agplus Diagnostics Ltd AI Business Plan
In just minutes, we combine Pomanda’s company and industry data with cutting edge Artificial Intelligence to build a comprehensive 27 section business plan. You then have 60 days to tailor the information, decide which sections to include or exclude, and add your own branding logos, images and color scheme to create your perfect plan.
Agplus Diagnostics Ltd Overview
Agplus Diagnostics Ltd is a live company located in london, WC2A 3LH with a Companies House number of 06994240. It operates in the manufacture of medical and dental instruments and supplies sector, SIC Code 32500. Founded in August 2009, it's largest shareholder is agplus holdings limited with a 100% stake. Agplus Diagnostics Ltd is a established, micro sized company, Pomanda has estimated its turnover at £415.5k with declining growth in recent years.
Upgrade for unlimited company reports & a free credit check
Agplus Diagnostics Ltd Health Check
Pomanda's financial health check has awarded Agplus Diagnostics Ltd a 1.5 rating. We use a traffic light system to show it exceeds the industry average on 2 measures and has 7 areas for improvement. Company Health Check FAQs
2 Strong
2 Regular
7 Weak
Size
annual sales of £415.5k, make it smaller than the average company (£9.6m)
- Agplus Diagnostics Ltd
£9.6m - Industry AVG
Growth
3 year (CAGR) sales growth of -12%, show it is growing at a slower rate (4%)
- Agplus Diagnostics Ltd
4% - Industry AVG
Production
with a gross margin of 42%, this company has a comparable cost of product (42%)
- Agplus Diagnostics Ltd
42% - Industry AVG
Profitability
an operating margin of -203.3% make it less profitable than the average company (5.1%)
- Agplus Diagnostics Ltd
5.1% - Industry AVG
Employees
with 4 employees, this is below the industry average (60)
4 - Agplus Diagnostics Ltd
60 - Industry AVG
Pay Structure
on an average salary of £52.9k, the company has an equivalent pay structure (£52.9k)
- Agplus Diagnostics Ltd
£52.9k - Industry AVG
Efficiency
resulting in sales per employee of £103.9k, this is less efficient (£140.8k)
- Agplus Diagnostics Ltd
£140.8k - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- Agplus Diagnostics Ltd
- - Industry AVG
Creditor Days
its suppliers are paid after 139 days, this is slower than average (42 days)
- Agplus Diagnostics Ltd
42 days - Industry AVG
Stock Days
it holds stock equivalent to 43 days, this is less than average (103 days)
- Agplus Diagnostics Ltd
103 days - Industry AVG
Cash Balance
has cash to cover current liabilities for 0 weeks, this is less cash available to meet short term requirements (25 weeks)
0 weeks - Agplus Diagnostics Ltd
25 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 2241.2%, this is a higher level of debt than the average (44.1%)
2241.2% - Agplus Diagnostics Ltd
44.1% - Industry AVG
agplus diagnostics ltd Credit Report and Business Information
Agplus Diagnostics Ltd Competitor Analysis
Perform a competitor analysis for agplus diagnostics ltd by selecting its closest rivals and benchmarking them against 12 key performance metrics.
agplus diagnostics ltd Ownership
AGPLUS DIAGNOSTICS LTD group structure
Agplus Diagnostics Ltd has no subsidiary companies.
agplus diagnostics ltd directors
Agplus Diagnostics Ltd currently has 2 directors. The longest serving directors include Mr Christopher Getley (Jul 2015) and Dr Suvir Venkataraman (Feb 2024).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Christopher Getley | United Kingdom | 60 years | Jul 2015 | - | Director |
| Dr Suvir Venkataraman | United Kingdom | 42 years | Feb 2024 | - | Director |
AGPLUS DIAGNOSTICS LTD financials
Agplus Diagnostics Ltd's latest turnover from December 2022 is estimated at £415.5 thousand and the company has net assets of -£4.9 million. According to their latest financial statements, Agplus Diagnostics Ltd has 4 employees and maintains cash reserves of £44.1 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Aug 2011 | Aug 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 606,877 | 1,447,853 | 88,423 | 366,418 | 90,222 | 85,994 | 84,000 | 122,000 | |||||
| Other Income Or Grants | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
| Cost Of Sales | 266,489 | 238,173 | 773,904 | 540,677 | 502,810 | 2,575,578 | 85,000 | 9,000 | |||||
| Gross Profit | 340,388 | 1,209,680 | -685,481 | -174,259 | -412,588 | -2,489,584 | -1,000 | 113,000 | |||||
| Admin Expenses | 951,354 | 1,597,215 | 289,627 | 434,592 | 418,870 | 188,690 | 227,000 | 289,000 | |||||
| Operating Profit | -610,966 | -387,535 | -975,108 | -608,851 | -831,458 | -2,678,274 | -228,000 | -176,000 | |||||
| Interest Payable | 5,735 | 746 | 16 | 47 | 0 | 287,909 | 176,000 | 69,000 | |||||
| Interest Receivable | 0 | 0 | 0 | 0 | 24,667 | 58,782 | 36,000 | 0 | |||||
| Pre-Tax Profit | -616,701 | -388,281 | -975,124 | -608,898 | -831,458 | -2,966,183 | -368,000 | -245,000 | |||||
| Tax | 108,710 | 145,210 | 123,173 | 111,489 | 0 | 250,000 | -8,000 | 0 | |||||
| Profit After Tax | -507,991 | -243,071 | -851,951 | -497,409 | -831,458 | -2,716,183 | -376,000 | -245,000 | |||||
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
| Retained Profit | -507,991 | -243,071 | -851,951 | -497,409 | -831,458 | -2,716,183 | -376,000 | -245,000 | |||||
| Employee Costs | 530,703 | 521,491 | 490,000 | 616,000 | |||||||||
| Number Of Employees | 4 | 8 | 9 | 10 | 11 | 11 | 9 | 9 | |||||
| EBITDA* | -583,767 | -340,153 | -876,590 | -536,833 | -820,805 | -2,636,173 | -187,000 | -128,000 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Aug 2011 | Aug 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 10,787 | 26,743 | 77,829 | 136,841 | 54,877 | 52,918 | 119,946 | 11,862 | 20,867 | 55,000 | 72,000 | 0 | 0 |
| Intangible Assets | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1,758,000 | 1,043,000 | 0 | 0 |
| Investments & Other | 1 | 238,350 | 476,700 | 476,700 | 476,700 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 10,789 | 265,094 | 554,530 | 613,542 | 531,578 | 52,919 | 119,947 | 11,863 | 20,867 | 1,813,000 | 1,115,000 | 0 | 0 |
| Stock & work in progress | 28,935 | 85,886 | 73,520 | 20,819 | 26,094 | 28,676 | 33,881 | 11,352 | 34,119 | 15,000 | 0 | 0 | 0 |
| Trade Debtors | 0 | 5,827 | 32,795 | 127,796 | 146,858 | 12,600 | 113,040 | 3,287 | 71,225 | 0 | 23,000 | 0 | 0 |
| Group Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Misc Debtors | 109,415 | 119,279 | 475,562 | 154,214 | 200,249 | 160,356 | 169,584 | 128,053 | 82,934 | 71,000 | 24,000 | 0 | 0 |
| Cash | 44,124 | 55,352 | 18,740 | 25,154 | 10,985 | 20,004 | 5,831 | 18,096 | 194,035 | 34,000 | 17,000 | 0 | 0 |
| misc current assets | 34,008 | 51,413 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current assets | 216,482 | 317,757 | 600,617 | 327,983 | 384,186 | 221,636 | 322,336 | 160,788 | 382,313 | 120,000 | 64,000 | 0 | 0 |
| total assets | 227,271 | 582,851 | 1,155,147 | 941,525 | 915,764 | 274,555 | 442,283 | 172,651 | 403,180 | 1,933,000 | 1,179,000 | 0 | 0 |
| Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 92,350 | 123,361 | 157,119 | 162,321 | 133,644 | 74,354 | 137,404 | 151,587 | 6,808 | 20,000 | 11,000 | 0 | 0 |
| Group/Directors Accounts | 4,964,779 | 4,423,270 | 3,898,248 | 3,008,515 | 2,325,382 | 1,842,041 | 1,074,405 | 300,000 | 3,555,811 | 15,000 | 15,000 | 0 | 0 |
| other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 8,163 | 9,716 | 8,381 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 36,504 | 59,579 | 72,082 | 188,399 | 358,606 | 43,217 | 63,580 | 56,761 | 77,922 | 74,000 | 78,000 | 0 | 0 |
| total current liabilities | 5,093,633 | 4,606,210 | 4,135,612 | 3,368,951 | 2,826,013 | 1,959,612 | 1,275,389 | 508,348 | 3,640,541 | 109,000 | 104,000 | 0 | 0 |
| loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2,345,000 | 1,220,000 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 8,163 | 17,879 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total long term liabilities | 0 | 0 | 0 | 8,163 | 17,879 | 0 | 0 | 0 | 0 | 2,345,000 | 1,220,000 | 0 | 0 |
| total liabilities | 5,093,633 | 4,606,210 | 4,135,612 | 3,377,114 | 2,843,892 | 1,959,612 | 1,275,389 | 508,348 | 3,640,541 | 2,454,000 | 1,324,000 | 0 | 0 |
| net assets | -4,866,362 | -4,023,359 | -2,980,465 | -2,435,589 | -1,928,128 | -1,685,057 | -833,106 | -335,697 | -3,237,361 | -521,000 | -145,000 | 0 | 0 |
| total shareholders funds | -4,866,362 | -4,023,359 | -2,980,465 | -2,435,589 | -1,928,128 | -1,685,057 | -833,106 | -335,697 | -3,237,361 | -521,000 | -145,000 | 0 | 0 |
| Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Aug 2011 | Aug 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||
| Operating Profit | -610,966 | -387,535 | -975,108 | -608,851 | -831,458 | -2,678,274 | -228,000 | -176,000 | |||||
| Depreciation | 15,956 | 75,969 | 27,199 | 47,382 | 98,518 | 72,018 | 10,653 | 42,101 | 41,000 | 48,000 | |||
| Amortisation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Tax | 108,710 | 145,210 | 123,173 | 111,489 | 0 | 250,000 | -8,000 | 0 | |||||
| Stock | -56,951 | 12,366 | 52,701 | -5,275 | -2,582 | -5,205 | 22,529 | -22,767 | 19,119 | 15,000 | 0 | 0 | 0 |
| Debtors | -15,691 | -383,251 | 226,347 | -65,097 | 174,151 | -109,668 | 151,284 | -22,819 | 83,159 | 24,000 | 47,000 | 0 | 0 |
| Creditors | -31,011 | -33,758 | -5,202 | 28,677 | 59,290 | -63,050 | -14,183 | 144,779 | -13,192 | 9,000 | 11,000 | 0 | 0 |
| Accruals and Deferred Income | -23,075 | -12,503 | -116,317 | -170,207 | 315,389 | -20,363 | 6,819 | -21,161 | 3,922 | -4,000 | 78,000 | 0 | 0 |
| Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash flow from operations | -546,215 | 8,167 | -721,957 | -606,521 | -651,601 | -2,497,721 | -229,000 | -86,000 | |||||
| Investing Activities | |||||||||||||
| capital expenditure | -1,649 | -805,388 | |||||||||||
| Change in Investments | -238,349 | -238,350 | 0 | 0 | 476,700 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| cash flow from investments | -1,649 | -805,388 | |||||||||||
| Financing Activities | |||||||||||||
| Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 541,509 | 525,022 | 889,733 | 683,133 | 483,341 | 767,636 | 774,405 | -3,255,811 | 3,540,811 | 0 | 15,000 | 0 | 0 |
| Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2,345,000 | 1,125,000 | 1,220,000 | 0 | 0 |
| Hire Purchase and Lease Commitments | 0 | -8,163 | -9,716 | -8,381 | 26,260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| share issue | |||||||||||||
| interest | -5,735 | -746 | -16 | -47 | 24,667 | -229,127 | -140,000 | -69,000 | |||||
| cash flow from financing | 669,547 | 508,855 | 767,620 | 774,358 | 501,978 | 966,506 | 985,000 | 1,266,000 | |||||
| cash and cash equivalents | |||||||||||||
| cash | -11,228 | 36,612 | -6,414 | 14,169 | -9,019 | 14,173 | -12,265 | -175,939 | 160,035 | 17,000 | 17,000 | 0 | 0 |
| overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| change in cash | -11,228 | 36,612 | -6,414 | 14,169 | -9,019 | 14,173 | -12,265 | -175,939 | 160,035 | 17,000 | 17,000 | 0 | 0 |
P&L
December 2022turnover
415.5k
-8%
operating profit
-844.7k
0%
gross margin
42.1%
+0.55%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2022net assets
-4.9m
+0.21%
total assets
227.3k
-0.61%
cash
44.1k
-0.2%
net assets
Total assets minus all liabilities
Similar Companies
agplus diagnostics ltd company details
company number
06994240
Type
Private limited with Share Capital
industry
72190 - Other research and experimental development on natural sciences and engineering
32500 - Manufacture of medical and dental instruments and supplies
incorporation date
August 2009
age
15
accounts
Total Exemption Full
ultimate parent company
previous names
argento diagnostics limited (September 2012)
incorporated
UK
address
66 lincoln's inn fields, london, WC2A 3LH
last accounts submitted
December 2022
agplus diagnostics ltd Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to agplus diagnostics ltd.
agplus diagnostics ltd Companies House Filings - See Documents
| date | description | view/download |
|---|
